224 related articles for article (PubMed ID: 7903097)
1. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo.
Levin D; Constant S; Pasqualini T; Flavell R; Bottomly K
J Immunol; 1993 Dec; 151(12):6742-50. PubMed ID: 7903097
[TBL] [Abstract][Full Text] [Related]
2. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation.
Krasteva M; Kehren J; Horand F; Akiba H; Choquet G; Ducluzeau MT; Tédone R; Garrigue JL; Kaiserlian D; Nicolas JF
J Immunol; 1998 Feb; 160(3):1181-90. PubMed ID: 9570532
[TBL] [Abstract][Full Text] [Related]
3. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
Guéry JC; Adorini L
J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
[TBL] [Abstract][Full Text] [Related]
5. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
6. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
Bianchi R; Grohmann U; Belladonna ML; Silla S; Fallarino F; Ayroldi E; Fioretti MC; Puccetti P
J Immunol; 1996 Aug; 157(4):1589-97. PubMed ID: 8759743
[TBL] [Abstract][Full Text] [Related]
7. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo.
Constant S; Schweitzer N; West J; Ranney P; Bottomly K
J Immunol; 1995 Oct; 155(8):3734-41. PubMed ID: 7561077
[TBL] [Abstract][Full Text] [Related]
8. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
[TBL] [Abstract][Full Text] [Related]
9. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
11. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
Dembic Z; Schenck K; Bogen B
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
[TBL] [Abstract][Full Text] [Related]
13. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
14. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.
Hermans IF; Ritchie DS; Daish A; Yang J; Kehry MR; Ronchese F
J Immunol; 1999 Jul; 163(1):77-81. PubMed ID: 10384102
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
16. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
17. CD40 is necessary for activation of naïve T cells by a dendritic cell line in vivo but not in vitro.
Haase C; Michelsen BK; Jørgensen TN
Scand J Immunol; 2004 Mar; 59(3):237-45. PubMed ID: 15030573
[TBL] [Abstract][Full Text] [Related]
18. Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.
Wells JW; Cowled CJ; Darling D; Guinn BA; Farzaneh F; Noble A; Galea-Lauri J
Cancer Immunol Immunother; 2007 Dec; 56(12):1861-73. PubMed ID: 17487489
[TBL] [Abstract][Full Text] [Related]
19. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.
Tao X; Grant C; Constant S; Bottomly K
J Immunol; 1997 May; 158(9):4237-44. PubMed ID: 9126985
[TBL] [Abstract][Full Text] [Related]
20. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
